Heterogeneity of monocytes in cancer
Authors:
- 1 January 2025
- journal article
- review article
- Published by e-Century Publishing Corporation in American Journal of Cancer Research
- Vol. 15 (8) , 3359-3375
Abstract
Monocytes, a crucial element of the innate immune system, act as the primary cells in the body’s immune response. Approved by the International Federation for Immunology in 2010, monocytes are categorized into three subsets based on the degree of cell surface molecule expression: classical monocytes, intermediate monocytes, and non-classical monocytes. Generally, different monocyte subsets have diverse responsibilities and can mutually transform to maintain the stability of the internal environment. Distinctions in functional characteristics and associations with diseases have been identified among the various monocyte subsets. This review aims to describe the expression and functions of monocytes in detail and discuss their roles in cancer immunity, which offers a novel approach for the diagnosis, treatment, and prognosis of tumors by exploring and summarizing the distribution of monocyte subsets in tumors. By delving into the distribution and functional characteristics of different monocyte subsets in tumors, it holds the promise of guiding individualized therapies and more precise tumor management.Keywords
This publication has 97 references indexed in Scilit:
- Monocyte recruitment during infection and inflammationNature Reviews Immunology, 2011
- SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subsetBlood, 2011
- Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsetsBlood, 2011
- Nomenclature of monocytes and dendritic cells in bloodBlood, 2010
- Tumour-derived microvesicles (TMV) mimic the effect of tumour cells on monocyte subpopulations.2010
- Comparison of gene expression profiles between human and mouse monocyte subsetsBlood, 2010
- Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytesBlood, 2007
- Preliminary study of mononuclear phagocytosis during breast cancer therapy.2007
- Phagocyte-specific S100 proteins: a novel group of proinflammatory moleculesTrends in Immunology, 2003
- CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony- stimulating factorBlood, 1995